Recent insider trading activity from Morris Charles Q, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Prelude Therapeutics Inc | $PRLD | Morris Charles Q | Chief Medical Officer | A | Employee Stock Option (right to buy) | 450000 | $4.70 | 450,000.0000 | 76,132,337 | 9999.99% | 0.59% |
| Feb. 13, 2025 | LAVA Therapeutics NV | $LVTX | Morris Charles Q | Chief Medical Officer | A | Share Options (Right to Buy) | 130850 | $0.00 | 130,850.0000 | 26,834,422 | 9999.99% | 0.49% |